Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
cancer
life sciences
national blog main
andrew berens
avapritinib
biotech
blueprint medicines
boston top stories
cancer immunotherapy
center for medicare and medicaid services
clinical trials
companion diagnostic
daniel o'day
deals
deciphera pharmaceuticals
fda
foundation medicine
foundationone cdx
foundationone heme
gastrointestinal stromal tumor
genentech
gist
gleevec
imatinib
national top stories
new york blog main
osimertinib
regorafenib
ripretinib
roche
rucaparib (rubraca)
san francisco blog main
steve hoerter
stivarga
sunitinib
sutent
svb leerink
What
medicine
morning
tumor
2
×
acquire
agreed
announced
approval
big
billion
blueprint
broad
cancer
chasing
confidence
deadly
deciphera
didn’t
drug
fda
filing
forms
foundation
gain
genentech
gi
momentum
panels
pay
pays
pharamceuticals
picked
plans
profiling
recently
redux
remaining
rest
roche
seek
share
Language
unset
Current search:
tumor
×
boston
×
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine